Public Company News
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Varonis Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action -VRNS
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Varonis Systems, Inc. (NASDAQ: VRNS) common stock between February 4, 2025 and October 28, 2025, both dates inclusive (the "...
2026-01-13 08:32
45
MISSION BANK OPENS NEW OFFICE IN NORTH SAN LUIS OBISPO COUNTY
BAKERSFIELD, Calif., Jan. 12, 2026 /PRNewswire/ -- Mission Bank has expanded existing operations in the Central Coast with the addition of a Loan and Deposit Production team located in North San Luis Obispo County. Led by Mark Pearce, and joined by Relationship Managers Sarah Kramer and Katie ...
2026-01-13 08:28
87
AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans
* AbbVie will provide low prices in Medicaid, and expand affordable, direct-to-patient offerings for treatments used by millions of Americans through TrumpRx * AbbVie will commit $100 billion in U.S. research and development (R&D) and capital investments, including manufacturing, over the nex...
2026-01-13 07:30
70
Secretary of War Visits Lockheed Martin F-35 Production Facility
FORT WORTH, Texas, Jan. 12, 2026 /PRNewswire/ -- Lockheed Martin (NYSE: LMT) welcomed Secretary of War Pete Hegseth to the Fort Worth, Texas, F-35 Lightning II production facility today. The visit was part of the secretary's Arsenal of Freedom industry tour and underscored Lockheed Martin's role ...
2026-01-13 06:43
30
DEFT Investors Have Opportunity to Lead DeFi Technologies, Inc. Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities ofDeFi Technologies, Inc. (NASDAQ: DEFT) between May 12, 2025 and November 14, 2025, both dates inclusive (the "Class Period"), of the important January 30, 2026 lea...
2026-01-13 06:41
39
KLAR INVESTOR ALERT: Hagens Berman Notifies Klarna Group plc (KLAR) Investors of Feb. 20 Deadline in IPO Securities Class Action
SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- National shareholder rights law firm Hagens Berman is notifying investors inKlarna Group plc (NYSE: KLAR) of the upcomingFebruary 20, 2026, lead plaintiff deadline in a pending securities class action. The firm is actively investigating the lawsuits cl...
2026-01-13 06:41
24
PRGO Deadline: PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
NEW YORK, Jan. 12, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026 lead...
2026-01-13 06:40
20
Datasea Announces Major Acoustic Technology Advancements in Brain-Computer Interface Applications
Acoustic-Driven Technologies Poised to Support Embodied Intelligence and Health Robotics Applications in a Multi-Billion-Dollar Brain–Computer Interface Market BEIJING, Jan. 12, 2026 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in aco...
2026-01-12 22:30
49
PlayNitride and Brillink Announce Strategic Collaboration to Advance Array-Based Photonic Interconnects
HSINCHU and MIAOLI, Jan. 12, 2026 /PRNewswire/ -- PlayNitride, a global leader in MicroLED technologies, today announced a strategic collaboration with Brillink to develop a next-generation array-based photonic interconnect solution designed to deliver longer reach, lower power consumption, and ...
2026-01-12 22:00
25
Insilico Medicine Completes First Patient First Dose in BETHESDA: A Phase II Trial for Garutadustat (ISM5411), the Gut-restricted AI-driven PHD Inhibitor for the Treatment of Inflammatory Bowel Disease
CAMBRIDGE, Mass., Jan. 12, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"),
a clinical-stage, generative AI-driven drug discovery company, today announced
the completion of first patient first dose in BETHESDA: a Phase IIa clinical
trial of ISM5411 (NCT07265570
2026-01-12 21:30
66
WuXi Biologics Launches Industry-Leading Digital Twin Platform PatroLab™ Designed to Transform Bioprocessing and Manufacturing
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of PatroLabTM, a state-of-the-art digital twin platform designed to transform bioprocess development and manufactur...
2026-01-12 21:09
41
CARsgen and Dispatch Bio Announce Clinical Collaboration to Evaluate Flare Platform and Zevor-cel in Solid Tumors
SHANGHAI, PHILADELPHIA and SAN FRANCISCO, Jan. 12, 2026 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, and Dispatch Bio, a biotech company engineering a universal treatment across solid tumors leveragin...
2026-01-12 21:05
37
ECARX Holdings Inc. Announces US$45.6 million Strategic Investment from Geely Holding Group
LONDON, Jan. 12, 2026 /PRNewswire/ -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced that it has entered into a subscription agreement with Geely Investment Holding Ltd. ("Geely Holding") onJanuary 8th, 2026. Under the terms of the a...
2026-01-12 20:04
90
Haisco Grants Global Rights of Innovative Drug HSK39004 to AirNexis in Deal Exceeding USD 1 Billion
HSK39004, a novel dual‑target therapy, aims to compete in the global COPD market, highlighting innovation and international capabilities BEIJING, Jan. 12, 2026 /PRNewswire/ -- On January 9, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an ex...
2026-01-12 20:00
44
Equity Acquisition of Nanyue Diankong (Hengyang) Industrial Technology
SINGAPORE, Jan. 12, 2026 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company"), one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), wishes to announce tha...
2026-01-12 19:00
131
TAL Education Group to Announce Third Quarter of Fiscal Year 2026 Financial Results on January 29, 2026
BEIJING, Jan. 12, 2026 /PRNewswire/ -- TAL Education Group ("TAL" or the "Company") (NYSE: TAL), a smart learning solutions provider inChina, today announced that it will release its unaudited financial results for the third quarter of fiscal year 2026 endedNovember 30, 2025, before the market o...
2026-01-12 17:30
26
WuXi AppTec Issues Positive Profit Alert for the Full Year of 2025
SHANGHAI, Jan. 12, 2026 /PRNewswire/ -- WuXi AppTec (stock code: 603259.SH/2359.HK), a leading global pharmaceutical CRDMO (Contract Research, Development, and Manufacturing Organization), today issued a Positive Profit Alert for the full year of 2025, disclosing forecasts of key operational data...
2026-01-12 17:30
42
XPENG Charts New Course in 2026: Flagship Launch, Sales Momentum, and AI Breakthrough Propel Global Technology Ambitions
GUANGZHOU, China, Jan. 12, 2026 /PRNewswire/ -- XPENG is ushering in 2026 with transformative momentum, reinforcing its strategic evolution into an AI-driven global technology leader. The company unveiled its next-generation flagship model, celebrated a critical production milestone, and introduc...
2026-01-12 16:14
42
Formosa Pharmaceuticals Announces Licensing Agreement with Samil Pharmaceuticals, Co., Ltd, for Commercialization of Clobetasol Propionate Ophthalmic Suspension for the Treatment of Inflammation and Pain Following Ocular Surgery
TAIPEI, Jan. 12, 2026 /PRNewswire/ -- Taiwan-based Formosa Pharmaceuticals ("Formosa", 6838.TW) announced today that the company has entered into an exclusive licensing agreement with Samil Pharmaceuticals, Co., Ltd ("Samil", 000520.KS), for exclusive rights to the commercialization of clobetasol...
2026-01-12 16:00
31
Tuya Smart Launches Aura, an AI Companion Robot Designed for Pets
LAS VEGAS, Jan. 12, 2026 /PRNewswire/ -- Tuya Smart (NYSE: TUYA, HKEX: 2391), a
global AI cloud platform service provider, officially unveiled Aura, its first
AI-powered pet companion robot, at CES 2026, the world's largest consumer
electronics show.
2026-01-12 13:25
28
Week's Top Stories
Most Reposted
Colebrook Bosson Saunders Launches Lana: An Adaptable Laptop Stand Engineered for Hybrid Work
[Picked up by 305 media titles]
2026-01-12 16:16
CAYIN AI: Revolutionizing Creativity and Global Communication
[Picked up by 300 media titles]
2026-01-12 16:34
Ready Server Announces Strategic Expansion into Japan with AT TOKYO Data Centre
[Picked up by 299 media titles]
2026-01-13 13:16
Novo Nordisk International Operations Commits to Veeva Vault CRM
[Picked up by 290 media titles]
2026-01-08 09:05Courtyard by Marriott Phuket, Patong Beach Resort: The Ultimate Family-Friendly Destination in 2026
[Picked up by 284 media titles]
2026-01-08 12:01
Most Read
J&T Express Hits Record 30 Billion Parcel Volume in 2025 with 22.2% YoY Growth
2026-01-07 06:53
6571
